The burgeoning popularity of tirzepatide , initially for blood sugar control , is creating significant attention within the United Kingdom , prompting a notable shift in hormone trends. Obtaining these medications remains a complex landscape, with NHS provision currently limited and specialist practices offering therapy at a higher cost . Worries a